Etiology of Prostate Cancer with the TMPRSS2:ERG Fusion: A Systematic Review of Risk Factors - Beyond the Abstract
TMPRSS2:ERG is the most common gene fusion in prostate cancer. Approximately 140,000 men in the United States are diagnosed with prostate cancer that has the TMPRSS2:ERG gene fusion annually, out of the approximately 300,000 new prostate cancer cases …